Yusuke Tanigawara

Predictive performance of the Bayesian analysis: Effects of blood sampling time, population parameters, and pharmacostatistical model

Koichi Nishimura, Masato Yasuhara, Ikuko Yano, 1994, Journal of Pharmacokinetics and Biopharmaceutics.

Comparison of the Pharmacokinetics of S-1, an Oral Anticancer Agent, in Western and Japanese Patients

Emmanuelle Comets, Yusuke Tanigawara, J. Wanders, 2003, Journal of Pharmacokinetics and Pharmacodynamics.

MICROMEDEX® Healthcare Series

Yusuke Tanigawara, Y. Tanigawara, Shizuka Yamazaki, 2004 .

Capacity-limited elimination of cefmetazole in rat

Kiyoshi Yamaoka, Yusuke Tanigawara, Y. Tanigawara, 1982 .

Moment analysis of drug disposition in kidney. V:In Vivo transepithelial transport ofp-aminohippurate in rat kidney

Yoshihiro Saito, Akira Kamiya, Yusuke Tanigawara, 1991, Journal of Pharmacokinetics and Biopharmaceutics.

Population pharmacokinetic modeling and model validation of a spicamycin derivative, KRN5500, in phase 1 study

Tomohiro Sudo, Yusuke Tanigawara, Y. Tanigawara, 2001, Cancer Chemotherapy and Pharmacology.

Application of PBPK Modeling and Virtual Clinical Study Approaches to Predict the Outcomes of CYP2D6 Genotype‐Guided Dosing of Tamoxifen

Yuichi Sugiyama, Wooin Lee, Kota Toshimoto, 2018, CPT: pharmacometrics & systems pharmacology.